DE69631041D1 - Promotor des utrophingens - Google Patents

Promotor des utrophingens

Info

Publication number
DE69631041D1
DE69631041D1 DE69631041T DE69631041T DE69631041D1 DE 69631041 D1 DE69631041 D1 DE 69631041D1 DE 69631041 T DE69631041 T DE 69631041T DE 69631041 T DE69631041 T DE 69631041T DE 69631041 D1 DE69631041 D1 DE 69631041D1
Authority
DE
Germany
Prior art keywords
pct
utrophin
date oct
sec
ability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69631041T
Other languages
English (en)
Other versions
DE69631041T2 (de
Inventor
Jonathon Mark Tinsley
Kay Elizabeth Davies
Carina Dennis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508236.8A external-priority patent/GB9508236D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of DE69631041D1 publication Critical patent/DE69631041D1/de
Application granted granted Critical
Publication of DE69631041T2 publication Critical patent/DE69631041T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4707—Muscular dystrophy
    • C07K14/4708—Duchenne dystrophy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69631041T 1995-04-24 1996-04-24 Promotor des utrophingens Expired - Lifetime DE69631041T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9508236.8A GB9508236D0 (en) 1995-04-24 1995-04-24 Promoting gene expression
GB9508236 1995-04-24
GBGB9526028.7A GB9526028D0 (en) 1995-04-24 1995-12-20 Promoting gene expression
GB9526028 1995-12-20
PCT/GB1996/000979 WO1996034101A1 (en) 1995-04-24 1996-04-24 Utrophin gene promoter

Publications (2)

Publication Number Publication Date
DE69631041D1 true DE69631041D1 (de) 2004-01-22
DE69631041T2 DE69631041T2 (de) 2004-09-02

Family

ID=26306918

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631041T Expired - Lifetime DE69631041T2 (de) 1995-04-24 1996-04-24 Promotor des utrophingens

Country Status (7)

Country Link
US (1) US5972609A (de)
EP (1) EP0824589B1 (de)
JP (1) JP4364941B2 (de)
AT (1) ATE256184T1 (de)
AU (1) AU712450B2 (de)
DE (1) DE69631041T2 (de)
WO (1) WO1996034101A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090544A (en) * 1995-07-26 2000-07-18 Creative Biomolecules, Inc. Methods and compositions for identifying morphogen analogs
US7306903B1 (en) 1995-07-26 2007-12-11 Curis, Inc. Methods and compositions for identifying morphogen analogs
US6103491A (en) * 1995-07-26 2000-08-15 Creative Biomolecules, Inc. Methods and compositions for identifying morphogen analogs
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6911307B1 (en) * 1998-12-08 2005-06-28 Proteus S.A. Method of detection in vitro of a target substance in a sample comprising the labelling of said substance with a reporter gene and with the sequences necessary for the expression of said reporter gene in vitro
GB9923423D0 (en) * 1999-10-04 1999-12-08 Isis Innovation Promoting gene expression
EP1366072A2 (de) * 2000-11-02 2003-12-03 Myocontract Ag Für ets-transkriptionsfaktor spezifischer promoter und transaktivatoren davon
CA2715080C (en) 2007-09-28 2021-09-28 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof

Also Published As

Publication number Publication date
ATE256184T1 (de) 2003-12-15
JP4364941B2 (ja) 2009-11-18
AU712450B2 (en) 1999-11-04
WO1996034101A1 (en) 1996-10-31
AU5404396A (en) 1996-11-18
US5972609A (en) 1999-10-26
DE69631041T2 (de) 2004-09-02
EP0824589A1 (de) 1998-02-25
JPH11504515A (ja) 1999-04-27
EP0824589B1 (de) 2003-12-10

Similar Documents

Publication Publication Date Title
Nissen et al. Molecular analysis of the transcriptional regulatory region of an early baculovirus gene
Nordqvist et al. Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs
Frankel et al. Cellular uptake of the tat protein from human immunodeficiency virus
Jones et al. Control of gene expression by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Multiple dioxin-responsive domains 5'-ward of the cytochrome P1-450 gene.
Abeles et al. P1 plasmid replication: replicon structure
Meyuhas et al. The mouse ribosomal protein L7 gene. Its primary structure and functional analysis of the promoter region.
US5358857A (en) Method of preparing fusion proteins
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
EP0786989A4 (de) Adenoassoziertes virus rep protein enthaltende lipidvesikel zur transgenen integration und gentheapie
FI950409A (fi) Yhdistelmä soluja, DNA-rakenteita, vektoreita ja menetelmiä fytaattia hajoittavien entsyymien ilmentämiseksi toivotuissa suhteissa
HK1022719A1 (en) Hamster ef-1 alpha transcriptional regulatory DNA
BR9914643A (pt) Vetores adeno-associados para expressão dofator viii por células alvo
ATE256184T1 (de) Promotor des utrophingens
Thompson et al. In vitro methylation of the promoter and enhancer of Pro alpha 1 (I) collagen gene leads to its transcriptional inactivation
Hwung et al. Cooperativity of sequence elements mediates tissue specificity of the rat insulin II gene
HU9300397D0 (en) Method for modifying tropism of micor-organisms to cells, tissues and host organisms recombinant micro-organisms obtained by this way and their application in human and veterinary medicine
WO1996003506A3 (en) Analog of haemophilus hin47 with reduced protease activity
ATE417114T1 (de) Promotor des utrophingens
Albright et al. Identification of a gene linked to Rhizobium meliloti ntrA whose product is homologous to a family to ATP-binding proteins
Larsson et al. VA RNAs from avian and human adenoviruses: dramatic differences in length, sequence, and gene location
CA2083396A1 (en) Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
DE69514217T2 (de) Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel
Bourdineaud et al. Characterization of the arcD arginine: ornithine exchanger of Pseudomonas aeruginosa. Localization in the cytoplasmic membrane and a topological model.
Moura-Neto et al. A 28-bp negative element with multiple factor-binding activity controls expression of the vimentin-encoding gene
KR910001046A (ko) 비융합 단백질을 제조하기 위한 미생물내 발현용 발현벡터

Legal Events

Date Code Title Description
8364 No opposition during term of opposition